Logo

Jubilant Integrates PathArt Database with FDA s Microarray Analysis Platform

Aug 10, 2004

NEW YORK, Aug. 10 (GenomeWeb News) - Jubilant Biosys said today that it has integrated PathArt, a database of over 900 signaling and metabolic pathways curated manually from the literature, with the US Food and Drug Administration's ArrayTrack DNA microarray analysis software system.

 

"The integration will allow users of ArrayTrack to use the built in plug-in to ... map the results of their analysis within ArrayTrack onto the pathways in PathArt," Sreenivas Devidas, vice president of business development and strategy at Jubilant, said in a statement. "The integration will allow the scientist to view the relevant hits in diseases, physiologies, and individual pathways, and [the] prioritization of targets for further research."

 

Breaking News
The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.